Senior finance executive and investor focused on growth-stage consumer and healthcare opportunities, with experience across corporate finance, strategy and board advisory. Cathleen Wrisberg has led capital-raising and M&A initiatives, advised management teams on go-to-market and scaling, and participates in private equity and venture investments. Market-oriented profile suited for board, advisory, and deal-sourcing roles.
Senior finance executive and investor focused on growth-stage consumer and healthcare opportunities, with experience across corporate finance, strategy and board advisory. Cathleen Wrisberg has led capital-raising and M&A initiatives, advised management teams on go-to-market and scaling, and participates in private equity and venture investments. Market-oriented profile suited for board, advisory, and deal-sourcing roles.
Focuses on growth-stage consumer and healthcare investments, prioritizing companies with repeatable unit economics and clear go‑to‑market paths. Prefers active, board-level engagement to drive capital efficiency, commercial scaling, and M&A preparation. Allocates capital with a medium-to-long horizon, blending venture and private equity instruments, and uses corporate finance experience to structure rounds and exits. Underwriting emphasizes operational KPIs, defensible customer acquisition economics, and regulatory awareness in healthcare. Risk discipline centers on staged capital deployment, milestone-based follow-ons, and alignment with management.
Focuses on growth-stage consumer and healthcare investments, prioritizing companies with repeatable unit economics and clear go‑to‑market paths. Prefers active, board-level engagement to drive capital efficiency, commercial scaling, and M&A preparation. Allocates capital with a medium-to-long horizon, blending venture and private equity instruments, and uses corporate finance experience to structure rounds and exits. Underwriting emphasizes operational KPIs, defensible customer acquisition economics, and regulatory awareness in healthcare. Risk discipline centers on staged capital deployment, milestone-based follow-ons, and alignment with management.
| Trades 1622 | Longs Won 1129/1622 69% | Profit Factor 9.24 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $523,171.36 |
| Average Win $185,381.93 | Best Trade (Aug 14) $8.17M | Sharpe Ratio -11.57 |
| Average Loss -$45,962.05 | Worst Trade (Aug 07) -$1.64M | Z-Score 10.52 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 1w 1d | Expectancy $115,151.23 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 22,727 | 20,455 | 18,182 | 15,909 | 13,636 | 11,364 | 9,091 | 6,818 | 4,545 | 2,273 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 39,366 | $8.3M | $12.24M | - | $3.94M | 47.44% | +0.524% |
ABBV AbbVie Inc. | 2,957 | $612,037.58 | $720,916.6 | - | $108,879.02 | 17.79% | 0.0 |
ACN Accenture plc Class A | 4,046 | $1.19M | $690,773.58 | - | -$500,095 | -41.99% | +0.176% |
ADI Analog Devices, Inc. | 1,244 | $283,956.19 | $473,080.77 | - | $189,124.58 | 66.6% | 0.0 |
AEP American Electric Power Company, Inc. | 1,699 | $223,068 | $218,066.67 | - | -$5,001.33 | -2.24% | 0.0 |
AER AerCap Holdings N.V. | 3,133 | $429,787 | $485,865.65 | - | $56,078.65 | 13.05% | 0.0 |
AFL Aflac Inc. | 4,055 | $363,070.47 | $509,145.8 | - | $146,075.33 | 40.23% | +0.328% |
AGG iShares Core U.S. Aggregate Bond ETF | 2,082 | $208,694.23 | $203,151.15 | - | -$5,543.08 | -2.66% | -0.087% |
AL Air Lease Corporation | 7,439 | $477,850.92 | $483,089 | - | $5,238.08 | 1.1% | +1.106% |
ALL Allstate Corporation | 8,981 | $1.52M | $2.36M | - | $833,797.7 | 54.7% | 0.0 |
AM Antero Midstream Corporation | 10,309 | $200,406.65 | $226,488.73 | - | $26,082.08 | 13.01% | +0.549% |
AMAT Applied Materials, Inc. | 862 | $221,783.38 | $475,867.1 | - | $254,083.72 | 114.56% | +0.993% |
AMD Advanced Micro Devices, Inc. | 2,057 | $428,541.66 | $1.07M | - | $638,177.44 | 148.92% | 0.0 |
AME Ametek Inc. | 11,947 | $2.07M | $2.89M | - | $818,607.34 | 39.56% | -4.857% |
AMGN Amgen Inc. | 1,914 | $560,739.06 | $746,498.26 | - | $185,759.2 | 33.13% | 0.0 |
AMZN Amazon.com Inc | 31,344 | $6M | $8.7M | - | $2.69M | 44.86% | 0.0 |
APH Amphenol Corporation | 10,952 | $184,464.54 | $469,101.54 | - | $284,637 | 154.3% | 0.0 |
ARKK ARK Innovation ETF Fund | 3,584 | $157,774.09 | $275,107.84 | - | $117,333.75 | 74.37% | 0.0 |
ARM Arm Holdings plc American Depositary Receipt | 6,889 | $1.06M | $1.9M | - | $835,605.58 | 78.73% | -1.85% |
AVEM Avantis Emerging Markets Equity ETF | 12,512 | $810,058.16 | $1.15M | - | $342,797.52 | 42.32% | -0.497% |